3-(5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl)benzoic acid, 95.0%, 100mg

spiro[chromane-2,3'-pyrrolidin]-4-one hydrochloride, 95.0%, 250mg

(S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid, 98%, 100mg

6-Aminobenzo[d][1,3]dioxole-5-carbaldehyde, 95+%, 250mg

3-allyl-6-ethoxybenzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 250mg

Citric acid, min. 99.5%, ultra pure, anhydrous, 10 kg, plastic packaging.

4-phenyl-2-hydrophthalazin-1-one, 98%, 95.0%, 25g

4-Amino-3-(trifluoromethyl)benzonitrile>98.0%(GC)1g

tert-Butyldimethyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)silane, 98+%, 25g

3-Methylbutyl(triphenyl)phosphanium;bromide, 97%, 100g

TRIS, 2.5 kg, plastic

1-(4-ethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-5-propyl-1H-pyrazole-4-carboxylic acid, 95.0%, 250mg

2-Chloro-4,5,7-trifluorobenzo[d]thiazole, 95.0%, 5g